Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
tear duct a non-functioning; and got shingles in my left eye; This serious case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a 83-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (Verbatim: and got shingles in my left eye) (serious criteria GSK medically significant) and blocked tear duct (excl congenital) (Verbatim: tear duct a non-functioning). The outcome of the ophthalmic herpes zoster was resolved (duration 4 months) and the outcome of the blocked tear duct (excl congenital) was not reported. The reporter considered the ophthalmic herpes zoster and blocked tear duct (excl congenital) to be related to Shingles vaccine. The company considered the ophthalmic herpes zoster and blocked tear duct (excl congenital) to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 02-MAR-2025 The patient was 83 years old. The reporter reported that definitely get the shot which was done in 2 sessions. The patient got the first one when it was not that affective and got shingles in his/her left eye. It was extremely painful. It took 4 months to clear up plus left his/her tear duct a non-functioning mess. The patient got the current one because if someone has had shingles, there was a good possibility of getting it again when older.; Sender's Comments: Ophthalmic herpes zoster and Dacryostenosis acquired are unlisted events which are considered unrelated to GSK Shingles vaccine.